30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Guttman-McCabe Christopher

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Guttman-McCabe Christopher's trades of Anterix Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15
US Anterix Inc (ATEX)
S Sale
47,762 -35.3%
206.84
US$3,626,408 		47,762 -35.3% 206.84 US$3,626,408
2026-06-17 2026-06-15
US Anterix Inc (ATEX)
S Sale
14,711 +7.7%
250.22
US$3,043,853 		14,711 +7.7% 250.22 US$3,043,853
2026-06-17 2026-06-15
US Anterix Inc (ATEX)
S Sale
57,512 +43.5%
238.35
US$1,664,865 		57,512 +43.5% 238.35 US$1,664,865
2026-06-17 2026-06-15
US Anterix Inc (ATEX)
S Sale
35,321 -20.9%
81.32
US$2,872,431 		35,321 -20.9% 81.32 US$2,872,431
2026-06-15 2026-06-15
US Anterix Inc (ATEX)
PrS Proposed sale
122,852
81.75
US$10,042,746 		122,852 81.75 US$10,042,746
2022-11-28 2022-11-25
US Anterix Inc (ATEX)
S Sale
8,332 -13.3%
36.21
US$301,660 		8,332 -13.3% 36.21 US$301,660
2021-02-19 2021-02-18
US Anterix Inc (ATEX)
S Sale
7,538 -17.1%
44.26
US$333,594 		7,538 -17.1% 44.26 US$333,594
2020-12-16 2020-12-16
US Anterix Inc (ATEX)
S Sale
1,590 -3.5%
29.75
US$47,302 		1,590 -3.5% 29.75 US$47,302